Nuveen’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-423,189
| Closed | -$1.29M | – | 3339 |
|
|
2024
Q4 | $1.29M | Sell |
423,189
-32,124
| -7% | -$140K | ﹤0.01% | 2593 |
|
|
2024
Q3 | $2.36M | Sell |
455,313
-600,749
| -57% | -$2.99M | ﹤0.01% | 2334 |
|
|
2024
Q2 | $2.71M | Buy |
1,056,062
+704,020
| +200% | +$2.4M | ﹤0.01% | 2231 |
|
|
2024
Q1 | $1.73M | Sell |
352,042
-181,154
| -34% | -$1.07M | ﹤0.01% | 2461 |
|
|
2023
Q4 | $4.69M | Sell |
533,196
-70,301
| -12% | -$576K | ﹤0.01% | 2019 |
|
|
2023
Q3 | $6.92M | Buy |
603,497
+201,103
| +50% | +$3.87M | ﹤0.01% | 1697 |
|
|
2023
Q2 | $10.2M | Buy |
402,394
+112
| +0% | +$3.49K | ﹤0.01% | 1500 |
|
|
2023
Q1 | $13M | Sell |
402,282
-98,565
| -20% | -$3.07M | ﹤0.01% | 1318 |
|
|
2022
Q4 | $9.24M | Sell |
500,847
-118,317
| -19% | -$2.71M | ﹤0.01% | 1546 |
|
|
2022
Q3 | $16.7M | Buy |
619,164
+260,044
| +72% | +$5.28M | 0.01% | 1136 |
|
|
2022
Q2 | $4.96M | Sell |
359,120
-11,701
| -3% | -$180K | ﹤0.01% | 1944 |
|
|
2022
Q1 | $7.07M | Sell |
370,821
-2,911
| -0.8% | -$44.1K | ﹤0.01% | 1861 |
|
|
2021
Q4 | $6.1M | Sell |
373,732
-10,932
| -3% | -$182K | ﹤0.01% | 2006 |
|
|
2021
Q3 | $10.7M | Sell |
384,664
-176,430
| -31% | -$5.03M | ﹤0.01% | 1728 |
|
|
2021
Q2 | $16.6M | Buy |
561,094
+104,771
| +23% | +$3.02M | 0.01% | 1511 |
|
|
2021
Q1 | $12.8M | Sell |
456,323
-19,826
| -4% | -$548K | ﹤0.01% | 1642 |
|
|
2020
Q4 | $13.5M | Buy |
476,149
+50,128
| +12% | +$1.3M | ﹤0.01% | 1508 |
|
|
2020
Q3 | $10.7M | Buy |
426,021
+25,165
| +6% | +$660K | ﹤0.01% | 1479 |
|
|
2020
Q2 | $9.79M | Buy |
400,856
+49,606
| +14% | +$979K | ﹤0.01% | 1499 |
|
|
2020
Q1 | $5.2M | Buy |
351,250
+24,534
| +8% | +$507K | ﹤0.01% | 1695 |
|
|
2019
Q4 | $5.3M | Buy |
326,716
+19,344
| +6% | +$300K | ﹤0.01% | 1963 |
|
|
2019
Q3 | $4M | Buy |
307,372
+104,035
| +51% | +$1.27M | ﹤0.01% | 2074 |
|
|
2019
Q2 | $2.64M | Buy |
+203,337
| New | +$2.56M | ﹤0.01% | 2298 |
|
Other funds holding RVNC
Nuveen's RVNC Position: Q1 2025 in Review
Nuveen sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 423,189 shares — an estimated $1.29M sold.
Nuveen first reported a position in RVNC in Q2 2019 and held it in 23 quarters. The position peaked at $16.7M in Q3 2022. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.
- Nuveen reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
- Nuveen sold 423,189 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $1.29M.
- Nuveen first reported a position in Revance Therapeutics, Inc. in Q2 2019 and held it in 23 quarters.
- Nuveen's Revance Therapeutics, Inc. position peaked at $16.7M in Q3 2022.
- 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.
Based on Nuveen's 13F filing for Q1 2025, filed 12 May 2025.